Advocacy & Education
Hyper-endemic typhoid in Africa takes spotlight at Cannes
September 13, 2011
New evidence draws attention to unrecognized burden in the region
CANNES, FRANCE – September 13, 2011 — Important new evidence revealing hyper-endemic typhoid in Africa will be presented by global health experts and scientists at the 6th International Conference on Vaccines for Enteric Diseases (VED) 2011 on September 14-16 in Cannes, France. The findings, presented by the Sabin Vaccine Institute’s Coalition against Typhoid (CaT), could help accelerate regional control of typhoid, a disease that afflicts 21.6 million people worldwide. This conversation is part of CaT’s ongoing effort to ensure the delivery of typhoid vaccines to the populations that need them most.
Members
Members of the Coalition Against Typhoid (CaT) include:
Aga Khan University
Bharat Biotech
Bill & Melinda Gates Foundation
Center for Vaccine Development at the University of Maryland
Crucell
Finlay Institute
GAVI Alliance
International Vaccine Institute
National Institutes of Health
Novartis Vaccines Institute for Global Health
Oxford University Clinical Research Unit at the Hospital for Tropical Diseases Vietnam
Oxford Vaccine Group at the University of Oxford
PATH
Sabin Vaccine Institute
Sanofi-Pasteur
Shantha Biotech
UNICEF
U.S. Centers for Disease Control and Prevention
Wellcome Trust
Wellcome Trust Sanger Institute
World Health Organization
Print this page
Email this page